PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A 4-week pilot study evaluated the effects of 2,000 mg daily manjistha (R. cordifolia) on human gut microbiota composition [PMID:32955913].
Extract ameliorates vitiligo by inhibiting the CXCL10/CXCL9/STAT1 signaling pathway in mouse models [PMID:40412781].
Reduced myocardial infarction area and restored arterial blood flow and contractility in mice [PMID:36875688].
Co-administration with Scutellaria baicalensis alleviated weight loss, colon shortening, and histopathological damage in DSS-induced colitis mice [PMID:40344969].
Attenuated neuropathy by inhibiting apoptosis and oxidative stress in rats [PMID:38004451].
Rubimaillin ameliorated liver fibrosis by triggering ferroptosis of activated hepatic stellate cells in mice [PMID:41694586].
Evidence summary
PubMed sources
- 1.PMID: 40412781 (2025) — Rubia cordifolia L. extract ameliorates vitiligo by inhibiting the CXCL10/CXCL9/STAT1 signaling pathway. · Journal of ethnopharmacology
- 2.PMID: 39183172 (2024) — Cytotoxic and Antitumor Agents from Genus Rubia. · Chemistry & biodiversity
- 3.PMID: 42208761 (2026) — A comprehensive review of Rubia medicinal plants: Traditional uses, botany, phytochemistry, and pharmacological activities. · Annales pharmaceutiques francaises
- 4.PMID: 32905089 (2020) — Influence of phytochemicals in induced psoriasis (Review). · Experimental and therapeutic medicine
- 5.PMID: 36875688 (2023) — Madder (Rubia cordifolia L.) Alleviates Myocardial Ischemia-Reperfusion Injury by Protecting Endothelial Cells from Apoptosis and Inflammation.